TNFα inhibitors (TNFαI) are indicated for several inflammatory diseases in children, including psoriasis, hidradenitis suppurativa, uveitis, inflammatory bowel disease (IBD) and juvenile idiopathic arthritis (JIA) [15, 16]. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.